Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 March, 2018 00:08 IST
Lupin launches generic Safyral tablets in United States
Source: IRIS | 14 Mar, 2018, 09.39AM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Tydemy (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg) are the generic equivalents of Bayer HealthCare Pharmaceuticals Inc.'s Safyral tablets. It is indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception.

Drospirenone, EE, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg tablets had annual sales of approximately USD 22 million in the US (IQVIA January 2018).

Shares of the company gained Rs 4.1, or 0.53%, to trade at  Rs 784.95.  The total volume of shares traded  was  5,849 at the BSE (9.29 a.m., Wednesday).

Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Ashok Leyland bags orders for 2,100 buses from Tamil Nadu - 21-Mar-2018 10:17
Suzlon designs and produces India's longest wind turbine blade - 21-Mar-2018 10:11
Mphasis partners with Plug and Play - 21-Mar-2018 09:55
Force Motors signs JV agreement with MTU Friedrichshafen GmbH - 21-Mar-2018 09:48
TCS partners with Saudi Real Estate Refinance Co - 21-Mar-2018 09:44
GE Power India secures contract worth Rs 3.09 bn - 21-Mar-2018 09:40
Alembic Pharm intimates of USFDA inspection of facility at Panelav - 21-Mar-2018 09:37
Mahindra & Mahindra partners with Standard Chartered - 20-Mar-2018 12:36
BHEL commissions 1st unit of Kishanganga hydro-electric project - 20-Mar-2018 10:12
Suzlon wins two projects of 300 MW and 200 MW each under SECI bid - 20-Mar-2018 10:08
Granules India receives approval for Metformin ER tablets - 20-Mar-2018 10:05
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer